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Abstract
The mammalian Msx homeobox genes, Msx1 and Msx2, encode transcription factors that control organogenesis and tissue
interactions during embryonic development. We observed overlapping expression of these factors in uterine epithelial and
stromal compartments of pregnant mice prior to embryo implantation. Conditional ablation of both Msx1 and Msx2 in the
uterus resulted in female infertility due to a failure in implantation. In these mutant mice (Msx1/2
d/d), the uterine epithelium
exhibited persistent proliferative activity and failed to attach to the embryos. Gene expression profiling of uterine
epithelium and stroma of Msx1/2
d/d mice revealed an elevated expression of several members of the Wnt gene family in the
preimplantation uterus. Increased canonical Wnt signaling in the stromal cells activated b-catenin, stimulating the
production of a subset of fibroblast growth factors (FGFs) in these cells. The secreted FGFs acted in a paracrine manner via
the FGF receptors in the epithelium to promote epithelial proliferation, thereby preventing differentiation of this tissue and
creating a non-receptive uterus refractory to implantation. Collectively, these findings delineate a unique signaling network,
involving Msx1/2, Wnts, and FGFs, which operate in the uterus at the time of implantation to control the mesenchymal-
epithelial dialogue critical for successful establishment of pregnancy.
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Introduction
Successful implantation is dependent on a timely progression of
a series of biological events during which the embryo undergoes
functional interactions with the uterus prepared by the maternal
factors [1–4]. During implantation, various tissue compartments
within the uterus, including luminal epithelium, glandular epi-
thelium, and stroma, undergo sequential proliferation and diffe-
rentiation as the embryo attaches to the luminal epithelium and
invades into the stroma. In mice, the luminal and glandular
epithelial cells are initially in a proliferative state on days 1 and 2 of
pregnancy. As pregnancy proceeds, these cells exit from the cell
cycle and enter a differentiation program that allows their
transition to a receptive state. The stromal cells adjacent to the
epithelium begin to proliferate on day 3 and this proliferation
becomes widespread following embryo attachment to the receptive
luminal epithelium on day 4 of pregnancy [1–4]. As the embryos
invade through the luminal epithelium into the stromal compart-
ment, the stromal cells differentiate into secretory decidual cells,
which support further growth and development of the implanted
embryos until placentation ensues [1–4].
Extensive research over the past decade, using genetically
altered mutant mouse models, has identified several factors that
critically regulate uterine function in the preimplantation or
postimplantation phases of pregnancy [5–11]. However, there is
only limited insight into the molecular mechanisms and signaling
pathways that interconnect the various cellular compartments of
the uterus to achieve receptivity to embryo implantation. Recent
studies in our laboratory indicated that a subset of fibroblast
growth factors (FGFs) produced by the stromal cells act in a
paracrine manner to promote luminal epithelial proliferation. The
transcription factor Hand2 suppresses the production of these
FGFs and inhibits luminal epithelial proliferation at the time of
implantation [11]. Studies by Lee et al identified Indian hedgehog
(IHH) as an epithelial paracrine factor that acts on the stromal
cells to regulate their differentiation [7]. These studies support the
concept that maternal competency for implantation is determined
by a critical exchange of diffusible signals between the epithelial
and stromal compartments, allowing transition of these tissues to
proper functional states that permit embryo attachment and
invasion. Identification of epithelial or stromal transcription factors
and their downstream molecular pathways that control these
signals is essential for a clear understanding of the molecular basis
of implantation.
It was previously reported that the messenger RNA encoding
the homeobox transcription factor MSX1 is expressed in the peri-
implantation uterus [12]. We observed that MSX2, another
member of MSX family, is expressed in a similar pattern in the
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during days 1–4 of pregnancy. Expressions of MSX1 and MSX2
were markedly reduced in both compartments following embryo
attachment. These findings raised the possibility that the pathways
regulated by MSX1 or MSX2 or both regulate the receptive state
of the preimplantation uterus. Global deletion of Msx1 and Msx2
gene is embryonic lethal, necessitating the development of
conditional deletion of these genes to study their functions during
implantation. Conditional ablation of either Msx1 or Msx2 showed
only modest impairment in embryo implantation, resulting in sub-
fertility of the mutant mice. On the other hand, conditional
ablation of both Msx1 and Msx2 in mouse uterus led to complete
infertility due to a failure of embryo attachment to the uterine
epithelium. We further established that Msx1 and Msx2 function
by suppressing the expression of several members of the Wnt
family. In Msx1/Msx2-null uterus, continued expression of a subset
of WNTs enhances b-catenin signaling in the stroma, which in
turn induces the expression of specific members of the fibroblast
growth factor (FGF) family in this compartment. One or more of
these FGFs act via the FGF receptors in the glandular and luminal
epithelial tissues to promote proliferation and prevent differenti-
ation. Lack of differentiation of the glandular epithelial cells results
in the failure to express critical factors, such as the leukemia
inhibitory factor (LIF), which are critical for implantation.
Additionally, undifferentiated luminal epithelial cells exhibit
persistent expression of MUC-1, a glycoprotein that serves as a
maternal barrier to the attachment of the embryo. This study,
therefore, delineated a novel signaling network downstream of
Msx1 and Msx2, mediating the stromal-epithelial crosstalk critical
for successful establishment of pregnancy.
Results
Msx1 and Msx2 are expressed in the preimplantation
uterus
The spatio-temporal profiles of mRNAs and proteins corre-
sponding to Msx1 and Msx2 were examined in the mouse uterus
during the preimplantation phase by real-time PCR and
immunohistochemistry (IHC), respectively. The expression of
both Msx1 and Msx2 mRNAs followed a similar pattern: an
increase on days 2–3 of pregnancy followed by a decline on day 4
at the time of embryo implantation (Figure 1A, left panel;
Figure 1B, left panel). Both MSX1 and MSX2 proteins were
expressed in uterine epithelium on day 1 of pregnancy (Figure 1A,
panel a; Figure 1B, panel a). The expression of these proteins
increased on days 2 and 3 of pregnancy and was localized to both
glandular epithelium and stroma (Figure 1A, panels b and c;
Figure 1B, panels b and c). The expression of MSX1 and MSX2
proteins then declined on day 4 at the time of embryo
implantation and were undetectable on day 5 (Figure 1A, panels
d & e; Figure 1B, panels d & e). Therefore, similar expression of
Msx1 and Msx2 was observed in the uterine epithelial and stromal
compartments in the preimplantation phase.
Ablation of Msx1 and Msx2 in the uterus leads to
infertility
To investigate the function of Msx1a n dMsx2 in the uterus, we
employed the Cre-LoxP strategy to create conditional single
knockout of Msx1 or Msx2 or double knockout of Msx1 and Msx2
in the uteri of adult mice. Transgenic mice expressing Cre under
the control of progesterone receptor (PR) promoter was
previously used to ablate ‘‘floxed’’ genes selectively in cells
expressing PR, including uterine cells [7–11]. We, therefore,
crossed the PR-Cre mice with mice harboring the ‘‘floxed’’ Msx1
or Msx2 or both to create Msx1
d/d, Msx2
d/d or Msx1
d/dMsx2
d/d
mice. We confirmed the deletion of Msx1 or Msx2 in the uteri of
these mutant mice by real-time PCR and IHC. As shown in
Figure S1, neither Msx1/Msx2 mRNA nor MSX1/MSX2
protein was detected in uteri of Msx1
d/dMsx2
d/d mice on day 3
of pregnancy, confirming successful abrogation of both Msx genes
in uteri of Msx1
d/dMsx2
d/d mice.
A six-month breeding study demonstrated that the single
mutant females, Msx1
d/d and Msx2
d/d, are subfertile but the
double mutant females, Msx1
d/dMsx2
d/d, are completely infertile
(Table 1). The subfertility of the single mutant Msx1
d/d or Msx2
d/d
was likely due to compensation of the function of one Msx gene by
the other. Indeed, in Msx1-null uteri, the level of Msx2 expression
in the uterus was markedly elevated (Figure S2).
While Msx1
f/fMsx2
f/f mice exhibited normal litter size and
pregnancy rates, the Msx1
d/dMsx2
d/d females failed to become
pregnant when mated with wild-type males. However, copulatory
plugs were observed upon mating, indicating normal mating
behavior. To investigate the cause of infertility in Msx1
d/dMsx2
d/d
females, we examined their ovarian functions by inducing
superovulation.PrepubertalMsx1
f/fMsx2
f/fand Msx1
d/dMsx2
d/d mice
were treated with a regimen of gonadotropin hormones as described
in Materials and Methods. We observed that, upon gonadotropin
stimulation, the number of eggs produced by Msx1
d/dMsx2
d/d was
comparable to that produced by the Msx1
f/fMsx2
f/f females (Figure
S3A), indicating that ovulation is not affected in the absence of Msx1
and Msx2. To further examine theovulation and fertilizationin these
mice under normal physiological conditions, blastocysts were
recovered from uteri of Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d mice
on day 4 of pregnancy prior to implantation. Once again, no
significant difference was found in either the number or the
morphology of the embryos recovered from Msx1
f/fMsx2
f/f and
Msx1
d/dMsx2
d/d uteri (Figure S3B and Figure 3C). In further support
of normal ovarian activity, the serum levels of progesterone and
estrogen were comparable in Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d
females on day 4 of pregnancy (Figure S3D and Figure S3E).
Collectively, these results suggested that the infertility of Msx1
d/d
Msx2
d/d females is not due to impairment in the hypothalamic-
Author Summary
During implantation, various tissue compartments within
the uterus, including epithelium and stroma, undergo
sequential proliferation and differentiation as the embryo
attaches to the uterus and invades into the maternal
tissue. There is only limited understanding of the
molecular signaling pathways that interconnect these
tissue compartments to achieve a functional state of the
uterus conducive to implantation. This study reveals that a
unique signaling network regulated by the homeobox
transcription factors MSX1 and MSX2 in the mouse uterus
critically controls female fertility. Targeted mutation of
Msx1 and Msx2 genes in female mice, which results in
infertility, established that these factors suppress signaling
by the morphogenic ligands, WNTS, in the uterus. In the
absence of Msx1 and Msx2, the WNT signaling is elevated,
leading to the production of a subset of fibroblast growth
factors (FGFs) in uterine stroma. These FGFs act in a
paracrine manner on the uterine epithelium to promote
epithelial proliferation, which results in lack of uterine
receptivity and implantation failure. This work, therefore,
uncovers an important mechanism in mammalian repro-
duction and development by identifying key paracrine
signals that arise from the uterine stroma to control
epithelial function during implantation.
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PLoS Genetics | www.plosgenetics.org 2 February 2012 | Volume 8 | Issue 2 | e1002500Figure 1. Expression of Msx1 and Msx2 in the uterus during early pregnancy. Real-time PCR was performed to monitor the expression of
mRNAs corresponding to Msx1 and Msx2 in uterus on days 1 to 5 of gestation. The relative levels of gene expression on different days of pregnancy
were determined by setting the expression level of Msx1 mRNA (A, Left panel) and Msx2 mRNA (B, Left panel) on day 1 of pregnancy at 1.0. Rplp0,
encoding a ribosomal protein, was used to normalize the level of RNA. Uterine sections from day 1 to day 5 (a–e) of pregnancy were subjected to
immunohistochemical analysis using anti-MSX1 (A, Right panel) and anti-MSX2 (B, Right panel) antibodies. Panel f shows uterine sections from day 3
pregnant mice treated with non-immune IgG. L, G and S indicate luminal epithelium, glandular epithelium and stroma, respectively.
doi:10.1371/journal.pgen.1002500.g001
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defective implantation or pregnancy failure following implantation.
Ablation of Msx1 and Msx2 in the uterus affects embryo
attachment to the luminal epithelium
In mice, the attachment of the embryos to the uterine wall
initiates the process of implantation. This is accompanied by
increased vascular permeability at the implantation sites, which
can be scored visually as distinct blue bands following an
intravenous injection of Chicago blue dye [13]. As shown in
Figure 2A, Msx1
f/fMsx2
f/f mice displayed distinct implantation
sites on day 5 of pregnancy. In contrast, the Msx1
d/dMsx2
d/d
females did not show any sign of implantation. Implanted embryos
were also assessed on days 6 and 7 of pregnancy by visual
inspection. Our results indicated that implantation sites are absent
in Msx1
d/dMsx2
d/d uteri (Figure 2A).
Histological analysis of Msx1
f/fMsx2
f/f females on day 5 of
pregnancy showed, as expected, a close contact of embryonic
trophectoderm with uterine luminal epithelium (Figure 2B, panel
a). In contrast, in Msx1
d/dMsx2
d/d uteri, embryos did not attach to
luminal epithelium. Instead, blastocysts remained free-floating in
the lumen and were readily recovered by uterine flushing of the
Msx1
d/dMsx2
d/d females (Figure 2B, panel b). Taken together,
these results indicated that the loss of Msx1 and Msx2 expression in
the uterus resulted in the inability of the luminal epithelium to
acquire competency for embryo implantation.
Estrogen receptor activity is elevated in uterine
epithelium of Msx1
d/dMsx2
d/d mice at the time of
implantation
In mice, the window of uterine receptivity is critically regulated
by the steroid hormones 17b-estradiol (E) and progesterone (P),
acting through their cognate nuclear receptors. We, therefore,
examined the expression levels of progesterone receptor (PGR),
estrogen receptor alpha (ESR1), and their downstream genes in
the uteri of Msx1
d/dMsx2
d/d mice by immunohistochemistry and
real-time PCR analyses. As shown in Figure 3A, the expression
levels of PGR (top panel) and ESR1 (middle panel) proteins in the
luminal epithelium or stromal compartment of Msx1
d/dMsx2
d/d
uteri were comparable to those of Msx1
f/fMsx2
f/f controls.
However, we noted that the expression of the transcriptionally
active form of ESR1, phosphorylated at serine 118 [14], was
markedly up-regulated in the luminal epithelial cells of Msx1
d/d
Msx2
d/d uteri, indicating that ER activity is elevated in the uterine
epithelia of these mice (lower panel). This observation indicated
that the pathways directed by Msx1/Msx2 play an important role
in controlling the ESR1 activity, which is normally suppressed in
uterine epithelium during the receptive phase [15–17]. Consistent
with this up-regulation of transcriptional activity of ESR1,
expression of mRNAs corresponding to well-known E-regulated
Table 1. Ablation of uterine Msx1 and Msx2 leads to female infertility.
Genotype No. of animals No. of Litters born
No. of litters per animal
(Mean ± SEM) No. of pups born
No. of pups per litter
(Mean ± SEM)
Msx1
f/fMsx2
f/f 6 32 5.360.2 261 8.160.4
Msx1
d/d 6 14 2.860.8 64 4.560.6
Msx2
d/d 6 22 3.660.6 132 6.060.5
Msx1
d/dMsx2
d/d 60 0 0 0
The results of a six-month breeding study are shown.
doi:10.1371/journal.pgen.1002500.t001
Figure 2. Lack of uterine Msx1 and Msx2 causes implantation
failure. A. Embryo implantation sites were examined in Msx1
f/fMsx2
f/f
and Msx1
d/dMsx2
d/d mice by the vascular permeability assay, which can
be scored as distinct blue bands (red arrows) following an injection of
Chicago blue dye on day 5 of pregnancy (D5, n=6) or direct eye-
visualization of implanted embryo on day 6 (D6, n=4) and on day 7 (D7,
n=4) of pregnancy. The graph represents the quantification of
implantation sites in Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d mice on day 5
of pregnancy. B. Failure of embryo attachment in Msx1
d/dMsx2
d/d uteri.
Histological analysis of uterine sections obtained from Msx1
f/fMsx2
f/f (a)
and Msx1
d/dMsx2
d/d (b) mice on day 5 (n=3) of pregnancy by
Hematoxylin and Eosin staining. Note the intimate contact between
embryo and luminal epithelium in Msx1
f/fMsx2
f/f mice and the free
floating embryo in the uterine lumen of Msx1
d/dMsx2
d/d mice. L and E
indicate luminal epithelium and embryo respectively.
doi:10.1371/journal.pgen.1002500.g002
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activated, family member 3 (Clca3) [19], lipocalin 2 [20] and mucin
1( Muc-1) [21], was significantly elevated in uterine epithelium of
Msx1
d/dMsx2
d/d uteri on day 4 of pregnancy (Figure 3B).
In contrast, the expression of Ihh, a P-responsive gene in uterine
epithelium [7] remained unaltered in Msx1
d/dMsx2
d/d uteri.
Additionally, the mRNA levels of Hand2 [11] and Hoxa10 [3],
well-known P-regulated genes in uterine stroma, and that of
chicken ovalbumin upstream promoter-transcription factor II
(COUP-TF II), a downstream target of IHH in the uterine stroma
[9], were unaffected in the uteri of Msx1
d/dMsx2
d/d mice
(Figure 3C). These results indicated that the loss of Msx1 and
Msx2 did not impact on the transcriptional activity of PGR, but
resulted in an enhancement of the epithelial ESR1 function.
A hallmark of the receptive state of normal pregnant uterus is
the cessation of epithelial cell proliferation prior to implantation
[1–4,22]. Therefore, in Msx1
f/fMsx2
f/f mice, immunostaining of
Ki67, a cell proliferation marker, was undetectable in the uterine
luminal and glandular epithelium on day 4 of pregnancy
(Figure 4A, panels a and c). However, uterine sections of Msx1
d/d
Msx2
d/d mice exhibited robust immunostaining for Ki67 in the
luminal and glandular epithelia (Figure 4A, panels b and d),
indicating persistent epithelial cell proliferation on day 4 in the
absence of Msx1 and Msx2. Previous studies indicated that the
ability of the glandular epithelium to undergo differentiation and
produce factors, including leukemia inhibitory factor (LIF) [23],
Foxa2 [24], and Spink3 [25], is critical for implantation. As shown
in Figure 4B, the expression of these factors was drastically
reduced in uteri deficient of Msx1 and Msx2. Collectively, these
findings indicated that persistent proliferation of luminal and
glandular epithelia results in impaired epithelial transition from a
proliferative to a non-proliferative state that allows proper
differentiation. This impairment is a major contributor to
implantation failure in Msx1
d/dMsx2
d/d mice.
Another important parameter of receptive uterus is the
membrane transformation of uterine epithelium at the time of
implantation. The presence of long microvilli, containing a thick
layer of glycoprotein known as the glycocalyx, on the uterine
epithelium is indicative of the nonreceptive stage. A marked
flattening of these microvilli occurs in the receptive phase prior to
implantation [26]. Transmission electron microscopy (TEM)
revealed that, in contrast to the control epithelium, the epithelia
of Msx1
d/dMsx2
d/d uteri fail to undergo appropriate remodeling to
promote microvilli flattening, indicating impaired uterine recep-
tivity in these mice (Figure 4C).
The impaired functional state of uterine epithelium in Msx1
d/d
Msx2
d/d mice was further confirmed when we analyzed the
expression of MUC-1 protein, a major component of the
endometrial glycocalyx, during early pregnancy. The expression
status of MUC-1 is considered an important indicator of uterine
Figure 3. Enhanced ESR1 activity in the luminal epithelium of Msx1
d/dMsx2
d/d uteri. A. Uterine sections obtained from Msx1
f/f Msx2
f/f (left
panel) and Msx1
d/dMsx2
d/d (right panel) mice on day 4 of pregnancy were subjected to IHC using antibodies against PGR (top panel, a and b), ESR1
(middle panel, c and d) and phospho-ESR1 (lower panel, e and f). B. Real-time PCR was performed to analyze the expression of E-regulated genes,
lactotransferrin (Ltf), Clca3, lipocalin2 and Muc-1 in uteri of Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d mice on day 4 of pregnancy. The level of Ck18 was used
as internal control to normalize gene expression. The data are represented as the mean fold induction 6 SEM, *p,0.05. C. Real-time PCR was
performed to analyze the expression of P-regulated genes, Ihh, COUP-TF II, Hand2 and Hoxa10, in uteri of Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d mice on
day 4 of pregnancy. The level of Rplp0 or Ck18 was used as internal control to normalize gene expression.
doi:10.1371/journal.pgen.1002500.g003
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uterus achieves receptivity, MUC-1 expression is down regulated in
this tissue. Persistent MUC-1 expression is indicative of a non-
receptive uterus, which is not conducive to embryo implantation. As
shown in Figure 4D, prominent expression of MUC-1 was detected
in the uterine epithelia of control Msx1
f/fMsx2
f/f mice on day 1 of
pregnancy (panel a). As the pregnancy advanced to days 4 (panel b)
and 5 (panel c), Muc-1 was progressively down regulated in uterine
epithelia of these mice, consistent with the attainment of receptive
status. In contrast, an intense expression of MUC-1 was observed in
uteriofMsx1
d/dMsx2
d/d miceondays4 and5 (panelsd–f).Therefore,
elevated epithelial ESR1 signaling, which likely triggered persistent
expression of MUC-1 in luminal epithelium, disrupted uterine
receptivity, resulting in implantation failure in Msx1
d/dMsx2
d/d mice.
Msx1/Msx2 regulates WNT and FGF signaling in the
uterus
To gain insights into the mechanisms underlying the implanta-
tion defect of uteri lacking Msx1 and Msx2, we isolated luminal
epithelial and stromal cells from Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d
uteri on day 4 of pregnancy and performed compartment-specific
gene expression profiling, using Affymetrix Mouse GeneChip
arrays. Interestingly, our study revealed up-regulation of two
distinct classes of signaling factors, WNTs and FGFs, in Msx1
d/d
Msx2
d/d uteri compared to Msx1
f/fMsx2
f/f uteri. The microarray
data (GEO accession #GSE30969) were validated by real-time
PCR analysis. In the epithelial compartment of Msx1
d/dMsx2
d/d
uteri, we observed stimulated expression of mRNAs corresponding
to several Wnts, including Wnt4, Wnt7a and Wnt7b (Figure 5A). In
the stromal cells of Msx1
d/dMsx2
d/d uteri, we observed marked up-
regulation of Wnt4 and Wnt5a mRNAs (Figure 5B). In addition, the
levels of mRNAs encoding severalmembers of the FGF family, such
as Fgf1, Fgf10, Fgf18 and Fgf21, wereelevated inuterine stromal cells
as a consequence of deletions of Msx1 and Msx2 (Figure 5C). The
expression of mRNAs corresponding to several other FGF family
members as well as other growth factors, such as HBEGF, EGF,
IGF-1, and, HGF which are expressed in the uterus during
pregnancy, was not significantly altered in the uterine stroma of
Msx1
d/dMsx2
d/d mice (Figure 5C and Figure S4).
We next investigated whether the increased expression of the
Wnt ligands in the uteri of Msx1
d/dMsx2
d/d mice is translated into
increased activation of the Wnt signaling pathway. Wnt signals are
transduced via the canonical Wnt/b-catenin-dependent pathway
or the non-canonical b-catenin-independent pathways [27–29].
Figure 4. Enhanced proliferation in the uterine epithelium and lack of receptivity in Msx1
d/dMsx2
d/d mice. A. Immunohsitochemical
localization of Ki67 in the uterine sections of Msx1
f/fMsx2
f/f (left panel, a and c) and Msx1
d/dMsx2
d/d (right panel, b and d) mice on day 4 of pregnancy.
Panels a and b indicate lower magnification (206) and c and d indicate higher magnification (406). L and G indicate luminal epithelium and glandular
epithelium respectively. B. Real-time PCR was performed to analyze the expression of glandular factors, Lif, Foxa2 and Spink3 in uteri of Msx1
f/fMsx2
f/f
and Msx1
d/dMsx2
d/d mice on day 4 of pregnancy. The level of Ck18 was used as internal control to normalize gene expression. The data are
represented as the mean fold induction 6 SEM, ***p,0.0001. C. Transmission electron microscopy of uterine sections obtained from Msx1
f/f Msx2
f/f
(left panel, a and b) and Msx1
d/dMsx2
d/d (right panel, c and d) mice on day 4 of pregnancy. Panels a and c indicate lower magnification (5Kx) and b and
d indicate higher magnification (30Kx). D. Immunohistochemical analysis of Muc-1 expression in the uterine sections of Msx1
f/fMsx2
f/f (upper panel)
and Msx1
d/dMsx2
d/d (lower panel) mice on day 1 (a and d), day 4 (b and e) and day 5 (c and f) of pregnancy. L indicates luminal epithelium.
doi:10.1371/journal.pgen.1002500.g004
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sections of Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d mice on day 4 of
pregnancy, we noted comparable levels of nuclear expression of
active b-catenin in luminal and glandular epithelium in both
genotypes (Figure 5D). However, a marked increase in the level of
nuclear b-catenin was observed in the stromal cells of Msx1Msx2-
null uteri, indicating that canonical b-catenin signaling is markedly
enhanced in the Msx1Msx2-ablated stroma.
Figure 5. Wnt/b-catenin signaling controls FGF synthesis in uterine stromal cells. A. Real-time PCR was performed to analyze the
expression of Wnt ligands in uterine epithelial cells of Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d mice on day 4 of pregnancy. The level of Ck18 was used as
internal control to normalize gene expression. The data are represented as the mean fold induction 6 SEM, *p,0.01, ***p,0.0001. B. Real-time PCR
was performed to analyze the expression of Wnt ligands in uterine stromal cells of Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d mice on day 4 of pregnancy. C.
Real-time PCR was performed to analyze the expression of Fgf family members in uterine stromal cells of Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d mice on
day 4 of pregnancy. The level of Rplp0 was used as internal control to normalize gene expression. The data are represented as the mean fold induction 6
SEM,*p,0.01,**p,0.001,***p,0.0001.D.Thelevelofactiveb-catenin in uterine sections of Msx1
f/fMsx2
f/f(left panel) and Msx1
d/dMsx2
d/d(right panel) mice
on day 4 of pregnancy was analyzed by IHC. (Magnification: a and c: 106,ba n dd :4 0 6) E. Primary stromal cells were isolated from uteri of Msx1
d/dMsx2
d/d
mice on day 3 of pregnancy and transfected with siRNA targeted to the b-catenin mRNA. Total RNA was isolated 24 h after transfection to analyze the
expression of Fgf family members by Real-time PCR. The level of Rplp0 was used as an internal control to normalize gene expression. The data are
represented as the mean fold induction 6 SEM, *p,0.01, **p,0.001, ***p,0.0001.
doi:10.1371/journal.pgen.1002500.g005
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FGFs, particularly FGF10 and FGF18, is stimulated downstream
of canonical Wnt signaling during certain cellular processes, such
as chick embryo development, bone development and human
hepatocellular carcinoma [30–32], raising the possibility that the
enhanced b-catenin signaling seen in uterine stromal cells of
Msx1
d/dMsx2
d/d mice may drive the increased FGF synthesis in
these cells. To test this possibility, primary stromal cells were
isolated from uteri of Msx1
d/dMsx2
d/d mice on day 3 of pregnancy
and transfected with siRNA targeted specifically to the b-catenin
mRNA. We observed that treatment with this siRNA resulted in
more than 80% reduction in b-catenin mRNA expression
compared to cells transfected with control (scrambled) siRNA
(Figure 5E). Most importantly, as shown in Figure 5E, siRNA-
mediated down regulation of b-catenin in the stromal cells led to a
significant reduction in expression of FGF10, FGF18, and FGF21.
However, the expression of FGF1 remained unaltered in cells
treated with b-catenin siRNA. These results indicated that
canonical Wnt signaling via b-catenin regulates the expression of
a specific subset of FGF family members in the uterine stromal cells.
We next investigated whether the increased production of FGFs
downstream of Wnt signaling leads to enhanced FGF receptor
(FGFR) signaling in the uteri of Msx1
d/dMsx2
d/d mice. Stimulation
of the cell surface FGFRs by FGF ligands leads to phosphorylation
of specific tyrosine residues in a critical docking protein, FGFR
substrate 2 (FRS2), which guides the assembly of distinct multi-
protein complexes, leading to the activation of either MAP kinase
or AKT signaling cascades [33–35]. We, therefore, investigated
the state of activation of the FGFR signaling pathway in the uteri
of Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d mice by monitoring the level
of phospho-FRS2. We observed only low level of phospho-FRS2
in the uterine luminal or glandular epithelium or stroma of
Msx1
f/fMsx2
f/f mice on day 4 of pregnancy (Figure 6A, panels a–c).
In contrast, a marked elevation in the level of phospho-FRS2 was
observed specifically in the luminal and glandular epithelium, but
not in the stroma (Figure 6A, panels d–f) of Msx1Msx2-null uteri,
indicating that FGFR signaling is increased in uterine epithelium
in the absence of Msx1/Msx2. Since the FGFs are produced in the
stroma of these mutant uteri, this finding suggests that they act in a
paracrine fashion via the FGFRs on the epithelial cells.
Figure 6. Enhanced FGFR signaling in the epithelium of Msx1
d/dMsx2
d/d uteri. A. The level of p-FRS2 was examined in the uterine sections of
Msx1
f/fMsx2
f/f (upper panel) and Msx1
d/dMsx2
d/d (lower panel) mice on day 4 of pregnancy by immunohistochemistry. Magnification: a and d: 106,b
and e: 206, c and f: 406. B. The level of p-ERK was examined in the uterine sections of Msx1
f/fMsx2
f/f (upper panel) and Msx1
d/dMsx2
d/d (lower panel)
mice on day 4 of pregnancy by immunohistochemistry. Magnification: a and d: 106, b and e: 206, c and f: 406. L, G and S indicate luminal
epithelium, glandular epithelium, and stroma respectively. C. FGFR-specific inhibitor PD173074 was applied to one uterine horn of Msx1
d/dMsx2
d/d
(n=3) mice on day 3 of pregnancy. The other horn served as vehicle-treated control. Uterine horns were collected on day 4 morning and sections
were subjected to immunohistochemistry to detect p-FRS2, Ki67, and Muc-1.
doi:10.1371/journal.pgen.1002500.g006
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activated downstream of FGF receptor signaling [33]. We,
therefore, investigated whether these pathways were activated in
the epithelia of Msx1Msx2-ablated uteri. As shown in Figure 6B,
phospho-ERK1/2 (pERK) was undetectable in the uterine
epithelium of Msx1
f/fMsx2
f/f mice on day 4 of pregnancy (panels
a–c). However, a dramatic increase in the immunostaining of
pERK1/2 was seen in epithelium of Msx1Msx2-null uteri on day 4
of pregnancy (panels d–f). In contrast, the expression of phospho-
AKT was undetectable in both of these genotypes (data not
shown), suggesting that the ERK1/2 pathway, rather than the
PI3K/AKT pathway, is the key downstream mediator of
enhanced FGFR signaling in Msx1Msx2-null uteri.
To examine whether the elevated mitogenic activity in the
luminal epithelium of Msx1
d/dMsx2
d/d uteri on day 4 of pregnancy
is indeed a result of the enhanced FGF signaling, we administered
PD173074, a FGFR-specific inhibitor [36], or vehicle into uterine
horns of Msx1
d/dMsx2
d/d mice in the pre-implantation phase. As
shown in Figure 6C, the epithelia of vehicle-treated uterine horns
of these mice showed strong expression of phospho-FRS2 on day 4
of pregnancy (panel a). Treatment with the FGFR inhibitor led to
a marked reduction in the level of phospho-FRS2 in the uterine
epithelium (Figure 6C, panel b). Concomitant with this down
regulation of FGFR signaling, we observed a decline in the
proliferative activity of Msx1Msx2-null uterine epithelia as well as
down-regulation of MUC-1 expression (Figure 6C, panels c–f).
Collectively, these results are consistent with the hypothesis that
increased FGF production, downstream of Wnt-b-catenin path-
way in Msx1Msx2-null uterine stroma, stimulates epithelial
proliferation by activating FGFR-ERK1/2 signaling pathway.
The proliferative epithelium fails to undergo differentiation,
resulting in persistent expression of MUC-1, which acts as a
major barrier to embryo attachment and implantation.
Discussion
Members of Msx family of homeobox genes, comprising of
Msx1, Msx2, and Msx3, are critical regulators of tissue morpho-
genesis [37–39]. While Msx1 and Msx2 are expressed in several
tissues during embryonic development, Msx3 expression is mostly
restricted to neural tube [40,41]. The present study describes the
expression of Msx1 and Msx2 in adult uterus and addresses their
roles in female reproduction. Using mutant mouse models
harboring conditional deletion of Msx1 and/or Msx2 in the
uterus, we established that these factors play critical roles in
regulating uterine function during implantation. Due to the
overlapping spatio-temporal expression of these two transcription
factors in uterine epithelium and stroma, it is not surprising that
female mice carrying deletion of either Msx1 or Msx2 are
subfertile, while those lacking both Msx1 and Msx2 are infertile.
We observed that the expression of Msx2 is markedly elevated in
Msx1-null uterus during early pregnancy (Figure S2), supporting
the concept that the loss of function of one Msx gene during early
pregnancy is partially compensated by the other.
Msx1 and Msx2 are critical regulators of the receptive state of
the uterus during implantation. Particularly interesting is the
finding that uterine expression of Msx1/Msx2 influences the
activity of b-catenin in the stroma, which in turn regulates
epithelial activity during early pregnancy. The identity of the
factors that function downstream of Msx1/Msx2 to regulate
stromal-epithelial cross-talk during implantation was revealed by
compartment-specific gene expression profiling of epithelial and
stromal cells collected from control and Msx1Msx2-ablated uteri.
We found that, in the absence of Msx1 and Msx2 in the uterus, the
expression of several WNT ligands was up-regulated in uterine
epithelial and stromal cells. While the expression of WNT4,
WNT7a, and WNT7b was elevated in the epithelium, that of
WNT4 and WNT5a increased in the stroma. With the exception
of WNT5a, these WNTs are known to signal via the canonical
pathway to release b-catenin from a complex with GSK3b,
leading to its stabilization and nuclear accumulation [27–29].
Nuclear b-catenin then associates with TCF/LEF family tran-
scription factors to regulate cellular gene expression. Consistent
with this scenario, a marked increase in the level of active b-
catenin was observed in uterine stromal cells of Msx1
d/dMsx2
d/d
uteri, while the active b-catenin levels remained unaltered in the
surface epithelium. Our results indicated that canonical Wnt
signaling is specificallyenhanced inthe stromal cellsasa consequence
of Msx1Msx2 ablation. How does Msx1/Msx2 regulate the WNTs
and whether the b-catenin activation in the stromal cells is driven by
WNTs originating in the epithelium or stroma, is unclear.
An important finding of this paper is that, in addition to WNTs,
the expression of several members of the FGF family is stimulated
in the stromal cells of Msx1
d/dMsx2
d/d uteri. The FGFs belong to a
large family of growth factors, comprising 23 distinct members
[33–35]. We observed that a subset of FGFs, including FGF1,
FGF10, FGF18 and FGF21, exhibited marked up-regulation in
uterine stroma of Msx1
d/dMsx2
d/d mice, indicating that the
expression of these growth factors are normally suppressed by
Msx1/Msx2. Interestingly, previous studies have shown that TCF/
LEF, activated downstream of WNT-b-catenin signaling in
colorectal cancer cells, binds to the promoter regions of FGF18
and FGF20 [30,31,42]. Studies have also shown that, in the chick
embryo, WNT-b-catenin signaling triggered the synthesis of FGF8
and FGF10, which control the initiation of limb development.
These previous findings suggested that WNT-activated b-catenin
regulates the expression of a subset of FGFs [30]. In the present
study, we provide direct evidence that active b-catenin regulates
the synthesis of the FGFs, particularly FGF10, FGF18, and
FGF21, in the stromal cells, uncovering a link between the WNT
and FGF signaling pathways in the endometrium. The precise
mechanism by which active b-catenin regulates the expression of
these FGFs in uterine stromal cells remains to be determined.
The FGFs exert their paracrine responses by binding to FGFRs
on the surface of the target cells and activating the receptor
tyrosine kinase pathway. It is well documented that signaling via
FGFRs leads to tyrosine phosphorylation of the docking protein
FRS2, followed by the recruitment of multiple distinct complexes,
which results in activation of Ras/ERK/MAP kinase and/or PI3
kinase/AKT signaling pathways in a variety of cell types [33,35].
In uteri lacking Msx1 and Msx2, the accumulation in the uterine
epithelium of phospho-FRS2, a key indicator of FGF signaling,
indicated activation of FGFR signaling. Bazer and his coworkers
have previously reported that the FGFRs are activated in ovine
uterine epithelia of sheep in response to the secretion of FGF7 and
FGF10 from the progesterone-primed mesenchyme and proposed
that these factors are potential regulators of the maternal-fetal
interactions [43,44]. However, in the mouse uterus, the expression
of FGF10, FGF18, and FGF21 is suppressed during the receptive
phase of implantation. The expression of these factors is induced
in the absence of Msx1 and Msx2, and the consequent increase in
FGFR signaling is associated with the lack of uterine receptivity
and implantation failure in Msx1
d/dMsx2
d/d mice.
The central hypothesis of this paper is that Msx1/Msx2 controls
uterine receptivity at the time of embryo implantation by
regulating epithelial function. During normal pregnancy in mice,
the uterus attains receptive status on day 4 of gestation when the
luminal and glandular epithelia cease to proliferate and begin to
differentiate. Our study suggests that, in the absence of Msx1 and
Msx Homeobox Genes Regulate Embryo Implantation
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the FGFRs to stimulate the ERK1/2 kinase pathway in both
luminal and glandular epithelia. As a consequence, the uterine
epithelia of Msx1
d/dMsx2
d/d mice remain proliferative and fail to
undergo transformation to the receptive state that allows embryo
attachment to initiate implantation. The activation of the ERK1/2
pathway in the epithelium also triggers phosphorylation of
epithelial ESR1 at serine-118. It is well established that this
phosphorylation event is critical for the transcriptional activation
of ESR1 [14]. An elevated ESR1 signaling in the epithelium is,
however, detrimental to the implantation process. For example,
ESR1 promotes the expression of Muc-1, a well-known cell surface
glycoprotein, which creates a barrier that prevents embryo
attachment. In mice, high levels of MUC-1 are present in the
non-receptive uterus on days 1 and 2 of pregnancy. As the
pregnancy progresses, MUC-1 expression declines in the epithe-
lium and it is drastically reduced on day 4 at the time of
implantation [21]. Therefore, the reduction of MUC-1 expression
is considered a sign of uterine receptivity in mice. The persistence
of high levels of MUC-1 in the Msx1
d/dMsx2
d/d uteri on day 4 of
pregnancy is indicative of hyperestrogenic activity in the luminal
epithelium and, consequently, reflects a lack of uterine receptivity.
Pathways downstream of Msx1 and Msx2 also control the
synthesis of glandular factors critical for uterine receptivity at the
time of implantation. While the uterine luminal epithelium is the
initial site of embryo attachment, the glandular epithelium is an
important source of paracrine factors required for the establish-
ment and maintenance of pregnancy [45]. As uterus acquires
competency for implantation, the glandular epithelial cells cease to
proliferate and undergo differentiation to express factors, such as
LIF and FOXA2, which are critical for embryo implantation
[23,24]. Presumably due to enhanced WNT and FGF signaling in
Msx1
d/dMsx2
d/d uteri, the glandular epithelial cells remain
proliferative and fail to express LIF and FOXA2. Consistent with
this hypothesis, a recent study has shown that expression of
constitutively active b-catenin in mouse endometrium leads to
enhanced proliferation and glandular hyperplasia [46].
We recently reported that the transcription factor HAND2
suppresses the production of a subset of FGFs, which act in a
paracrine manner to stimulate the proliferation of the luminal
epithelium [11]. Conditional deletion of Hand2 in the uterus also
results in the failure of implantation due to impaired uterine
receptivity caused by increased production of FGFs in the stroma.
The uterine phenotype of Hand2 deletion is remarkably similar to
those of Msx1/Msx2 ablation. We, therefore, examined whether
Hand2 is regulated by Msx1/Msx2 or vice versa. Surprisingly, our
studies showed that Msx1/Msx2 expression is unaltered in Hand2–
null uteri (Figure S5). Similarly, the loss of Msx1 or Msx2 or both
did not affect Hand2 expression in the uterus during implantation
(Figure S6). Furthermore, while Hand2 coordinately suppresses the
expression of FGF1, FGF2, FGF9 and FGF18, Msx1/Msx2
inhibits the expression of FGF1, FGF10, FGF18, and FGF21.
Although these results suggest that one or more of these FGFs act
in a paracrine manner through the epithelial FGFRs to promote
epithelial cell proliferation, the contribution of each these FGFs is
unclear and, therefore, it remains to be determined whether Hand2
and Msx1/Msx2 function via similar or distinct mechanisms.
In summary, we have uncovered a novel mechanism by which
Msx1/Msx2 regulates epithelial function at the time of implantation.
In normal pregnancy, these factors actto repress WNT and b-catenin
signaling and inhibit FGF synthesis in the uterine stroma, thereby
attenuating the paracrine mechanisms that promote epithelial
proliferation. It is also evident that the activation of ERK1/2 kinase
pathway downstream of FGFR signaling in the epithelium of
Msx1Msx2-ablated uteri activates transcriptional function of ESR1,
contributing to the non-receptive status of the uterus (Figure 7).
Figure 7. Mechanism of Msx1 and Msx2 action in mouse uterus. In normal pregnancy, MSX1 and MSX2 act to repress WNT and b-catenin
signaling and inhibit FGF synthesis in the uterine stroma, thereby suppressing stromal-epithelial cross-talk. In the absence of MSX1 and MSX2, FGFs
are induced, activating the epithelial FGFR-ERK1/2 pathway, and promoting epithelial proliferation. Activated ERK1/2 then phosphorylates epithelial
ESR1. This triggers transcriptional activation of ESR1 and expression of its target genes, such as Muc-1, which prevent the functional transformation of
the luminal epithelium to receptive state, blocking embryo implantation.
doi:10.1371/journal.pgen.1002500.g007
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controlthe WNT-b-catenin-FGFpathway to directuterine stromal-
epithelial communication will clarify our understanding of the
molecular events that underlie uterine receptivity.
Materials and Methods
Animals
Mice were maintained in the designated animal care facility at
the College of Veterinary Medicine of the University of Illinois,
Urbana-Champaign, according to the institutional guidelines
for the care and use of laboratory animals. To generate the
conditional Msx1Msx2-null mice (Msx1
d/dMsx2
d/d), Msx1Msx2-
floxed (Msx1
f/fMsx2
f/f) [47] mice were mated with PR-Cre
knock-in mice [48].
For breeding studies, cycling Msx1
d/dMsx2
d/d and Msx1
f/fMsx2
f/f
female mice (C57BL/6 genetic background) were housed with
wild-type C57BL/6 male mice (Charles Rivers) for 6 months. The
presence of a vaginal plug after mating was designated as day 1 of
pregnancy. The number of litters and pups born were recorded at
birth to assess the fertility status.
To induce superovulation, 3-week old female mice were
administered intraperitoneally with 5 IU of pregnant mare serum
gonadotrophin (PMSG, Sigma St. Louis, MO) followed by 5 IU of
human chorionic gonadotropin (hCG, Sigma St. Louis, MO)
48 hours later. The mice were killed 16–18 hours post-hCG
administration and the oocytes were recovered from the ampulla
and counted.
To collect blastocysts, 8-week old female mice were mated with
wild-type males. To assess the pre- implantation development of
embryos, blastocysts were flushed from day 4 pregnant uteri and
examined for their quality under a stereo-zoom microscope.
For certain experiments, the FGFR-specific inhibitor, PD173074
(Selleck Chemicals Co., Ltd., London ON, Canada), was dissolved
in DMSO and was diluted with HBSS. Ten microlitre of inhibitor
(50 mM) was injected intraluminally in one horn and vehicle was
injected in the other horn of Msx1
d/dMsx2
d/d mice on day 3 of
pregnancy. Uterine tissues were collected on day 4 of pregnancy.
Transmission electron microscopy
Uterine tissues isolated from Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d
female mice on day 4 of pregnancy were fixed in 2.0%
paraformaldehyde and 2.5% glutaraldehyde in buffer containing
0.1 M sodium cacodylate. Tissues were then washed and fixed
with 1.0% aqueous osmium tetroxide in 0.1 M sodium cacodylate
buffer. Following dehydration with ethanol and propylene oxide,
the tissues were embedded in 100% Polybed 812 mixture. Sections
(80 nm) were cut with an Ultramicrotome, stained and examined
under a Philips CM 200 Transmission Electron Microscope.
Isolation of uterine epithelial and stromal cells
Uterine epithelial cells were isolated as previously described
[49]. Briefly, uterine horns were dissected into 3–4 mm pieces
and incubated in a solution of 1% trypsin (Difco, Dertroit, MI) in
Hank’s balanced salt solution (HBSS) for 90 min at 4uC and then
for 30 min at room temperature. The tissues were then rinsed
with 10% FBS. Under a dissecting microscope, each enzyme
treated piece of uterus was squeezed by forceps to separate the
epithelium from the rest of the uterine tissue. Uterine stromal
cells were isolated as previously described [50]. Briefly, uterine
horns of pregnant mice were dissected and placed in HBSS
containing 6 g/liter dispase and 25 g/liter pancreatin for 1 h at
room temperature and then 15 min at 37uC to remove the
endometrial epithelial clumps. The tissues were then placed in
HBSS containing 0.5 g/liter collagenase for 45 min at 37uCt o
disperse the stromal cells. After vortexing, the contents were
passed through a 70-mm gauze filter (Millipore). The filtrate
contained the stromal cells.
Culture of uterine stromal cells
The uterine stromal cells, isolated as described above, were
diluted in Dulbecco’s modified Eagle’s Medium-F12 medium
(DMEM-F12; with 100 unit/liter penicillin, 0.1 g/liter strepto-
mycin, 1.25 mg/liter Fungizone) with 2% heat-inactivated fetal
calf serum. The live cells were counted by trypan blue staining
using a hemocytometer. Cells were then seeded in 6-well cell
culture plates. The unattached cells were removed by washing
several times with HBSS after 2 h, and cell culture was continued
after addition of fresh medium supplemented with P (1 mm) and E
(10 nm).
Quantitative real-time PCR analysis (qPCR)
Uterine tissue was homogenized and total RNA was extracted
by using TRIZOL reagent, according to the manufacturer’s
protocol. cDNA was prepared by standard protocols. The cDNA
was amplified to quantify gene expression by quantitative PCR,
using gene-specific primers and SYBR Green (Applied Biosys-
tems, Warringtom, UK). The expression level of RPLP0 (36B4)
or Cytokeratin 18 (Ck18) was used as the internal control. For
each treatment, the mean Ct and standard deviation were
calculated from individual Ct values obtained from three
replicates of a sample. The normalized DCt in each sample
was calculated as mean Ct of target gene subtracted by the mean
Ct of internal control gene. DDCt was then calculated as the
difference between the DCt values of the control and treatment
sample. The fold change of gene expression in each sample
relative to a control was computed as 2
2DDCt.T h em e a nf o l d
induction and standard errors were calculated from three or
more independent experiments.
Immunohistochemistry
Uterine tissues were processed and subjected to immunohisto-
chemistry as described previously [13]. Briefly, paraffin-embedded
tissues were sectioned at 5 mm and mounted on microscopic slides.
Sections were deparaffinized in xylene, rehydrated through a
series of ethanol washes, and rinsed in water. Antigen retrieval was
performed by immersing the slides in 0.1 M citrate buffer solution,
pH 6.0, followed by microwave heating for 25 min. The slides
were allowed to cool and endogenous peroxidase activity was
blocked by incubating sections in 0.3% hydrogen peroxide in
methanol for 15 min at room temperature. After washing with
PBS for 15 min and the slides were incubated in a blocking
solution for 1 h before incubating them in primary antibody
overnight at 4uC with antibodies specific for MSX1 (Abcam,
ab73883), MSX2 (Santa Cruz, sc-15396), MUC1 (Novus biolog-
ical, NB120-15481), Ki67 (BD Pharmingen, 550609), ESR1
(Santa Cruz, sc-7207), p-ESR1 (Santa Cruz, sc-12915), PGR
(Neomarkers MS-194-PO), HAND2 (Santa Cruz sc-9409),
phospho-FRS2 (R&D systems AF5126) and active b-catenin
(PY489, Developmental Studies Hybridoma Bank, Iowa City, IA
52242). The slides were incubated with the biotinylated secondary
antibodies at room temperature for 1 h, followed by incubation
with horseradish peroxidase-conjugated streptavidin (Invitrogen
Corp., MD 21704). The sections were stained in 3-amino-9-
ethylcarbazole chromogen (AEC) solution until optimal signal was
developed. Sections were counterstained with Mayer’s Hematox-
ylin and examined by bright field microscopy.
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Control (scrambled) siRNA and siRNA targeted to b-catenin
(s438) were purchased from Ambion Inc. The transfection was
performed using SilentFect
TM Reagent (Bio-Rad), according to
the manufacturer’s protocol. The stromal cells were isolated from
uteri of Msx1
d/dMsx2
d/d mice on day 3 of pregnancy and
transfected with siRNA after 5–6 h of culture. The cells were
harvested 24 h following transfection and RNA was isolated.
DNA microarray analysis
Uterine epithelial and stromal cells were isolated from Msx1
f/f
Msx2
f/f and Msx1
d/dMsx2
d/d mice on day 4 of pregnancy. Total
RNA was prepared from these cells, and hybridized to Affymetrix
GeneChip Mouse Genome 430 2.0 array as previously described
[6]. They were processed and analyzed according to the
Affymetrix protocol.
Measurement of serum E and P levels
The levels of E and P in the serum were measured by
radioimmunoassay (RIA) performed at the Ligand Core facility of
the University of Virginia at Charlottesville.
Statistical analysis
Statistical analysis was performed by t-test or ANOVA. The
values were expressed as mean 6 SEM and considered significant
if p,0.05.
Supporting Information
Figure S1 Loss of Msx1 and Msx2 expression in the uterus of
Msx1
d/dMsx2
d/d mice. A. Uterine RNA was extracted from Msx1
f/f
Msx2
f/f and Msx1
d/dMsx2
d/d mice on day 3 of pregnancy (n=3)
and analyzed by real-time PCR. Relative levels of Msx1 and Msx2
mRNA expression in uteri of Msx1
d/dMsx2
d/d mice are compared
to those in Msx1
f/fMsx2
f/f control mice. The data are represented
as the mean fold induction 6 SEM, **p,0.001. B. Uterine
sections obtained from day 3 pregnant Msx1
f/fMsx2
f/f (left panel)
and Msx1
d/dMsx2
d/d (right panel) mice were subjected to
immunohistochemical analysis. Note the lack of Msx1 (upper
panel) and Msx2 (lower panel) immunostaining in the uteri of the
mutant mice. L, G and S indicate luminal epithelium, glandular
epithelium and stroma respectively.
(TIF)
Figure S2 Expression of Msx2 is elevated in the uterus of Msx1
d/d
mice. Left Panel. Uterine RNA was purified from Msx1
f/f and
Msx1
d/dmiceonday3andday4ofpregnancyandanalyzedbyreal-
time PCR. Relative levels of Msx2 mRNA expression in uteri of
Msx1
d/d mice are compared to those in Msx1
f/f control mice. Right
Panel. Uterine sections obtained from day 3 and day 4 pregnant
Msx1
f/f (upper panel) and Msx1
d/d (lower panel) mice were subjected
to immunohistochemical analysis to detect MSX2. Note the
elevated levels of MSX2 immunostaining in the uteri of Msx1
d/d
mice.
(TIF)
Figure S3 Ovarian functions and preimplantation events remain
unaffected in Msx1
d/dMsx2
d/d mice. A. Age-matched prepubertal
Msx1
f/fMsx2
f/f (n=7) and Msx1
d/dMsx2
d/d mice (n=6) were
subjected to superovulation. The oocytes were recovered and
counted at 18 h after hCG administration (values are mean 6
SEM). B. Pre-implantation embryos were recovered from uteri of
Msx1
f/fMsx2
f/f (n=7) and Msx1
d/dMsx2
d/d mice (n=12) in the
morning of day 4 of pregnancy, counted (values are mean 6 SEM)
and photographed. C. Representative morphology of blastocysts
recovered from uteri of Msx1
f/fMsx2
f/f and Msx1
d/dMsx2
d/d mice.
D & E: P and E levels in serum of Msx1
f/fMsx2
f/f (n=6) and
Msx1
d/dMsx2
d/d (n=10) mice on day 4 of pregnancy. Values are
represented as means 6 SEM.
(TIF)
Figure S4 Expression of Egf family of growth factors in Msx1
d/d
Msx2
d/d uteri. Real-time PCR was performed to monitor the
expression of Egf family of growth factors in the uterine stroma of
Msx1
f/f Msx2
f/f and Msx1
d/dMsx2
d/d mice on day 4 of pregnancy.
(TIF)
Figure S5 Msx1 and Msx2 expression in Hand2
d/d uteri. The
levels of MSX1 (upper panel) and MSX2 (lower panel) were
examined in the uterine sections of Hand2
f/f (left panel) and
Hand2
d/d (right panel) mice on day 3 of pregnancy by IHC.
(TIF)
Figure S6 Hand2 expression in Msx1
d/dMsx2
d/d uteri. The level
of Hand2 in uterine sections of Msx1
f/fMsx2
f/f (left panel) and
Msx1
d/dMsx2
d/d (right panel) mice on day 4 of pregnancy was
analyzed by IHC (Magnification: upper panel: 206, lower panel:
406).
(TIF)
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